Airlane Alencar

Dr. Airlane Alencar

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2013 in Emerging Infectious Diseases
Verified
Journal Article
Open access
EAEliane Terezinha Afonso
Eliane Terezinha Afonso
RMRuth Minamisava
Ruth Minamisava
ABAna Luiza Bierrenbach
Ana Luiza Bierrenbach
JEJuan Jose Cortez Escalante
Juan Jose Cortez Escalante
AAAirlane Alencar
Airlane Alencar
AAAna Lucia Andrade
Ana Lucia Andrade
Pneumonia is most problematic for children in developing countries. In 2010, Brazil introduced a 10-valent pneumococcal conjugate vaccine (PCV10) to its National Immunization Program. To assess the vaccine’s effectiveness for preventing pneumonia, we analyzed rates of hospitalization among children 2–24 months of age who had pneumonia from all causes from January 2005 through August 2011. We used data from the National Hospitalization Information System to conduct an interrupted time-series analysis for 5 cities in Brazil that had good data quality and high PCV10 vaccination coverage. Of the 197,975 hospitalizations analyzed, 30% were for pneumonia. Significant declines in hospitalizations for pneumonia were noted in Belo Horizonte (28.7%), Curitiba (23.3%), and Recife (27.4%) but not in São Paulo and Porto Alegre. However, in the latter 2 cities, vaccination coverage was less than that in the former 3. Overall, 1 year after introduction of PCV10, hospitalizations of children for pneumonia were reduced.

1 September 2015 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
ISItamar Santos
Itamar Santos
AAAirlane Alencar
Airlane Alencar
TRTatjana Rundek
Tatjana Rundek
AGAlessandra C. Goulart
Alessandra C. Goulart
SBSandhi Maria Barreto
Sandhi Maria Barreto
PLPaulo A. Lotufo
Paulo A. Lotufo
Objective—: There is little information about how much traditional cardiovascular risk factors explain common carotid artery intima-media thickness (CCA-IMT) variance. We aimed to study to which extent CCA-IMT values are determined by traditional risk factors and which commonly used measurements of blood pressure, glucose metabolism, lipid profile, and adiposity contribute the most to this determination in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) cohort baseline. Approach and Results—: We analyzed 9792 individuals with complete data and CCA-IMT measurements. We built multiple linear regression models using mean left and right CCA-IMT as the dependent variable. All models were stratified by sex. We also analyzed individuals stratified by 10-year coronary heart disease risk and, in separate, those with no traditional risk factors. Main models’ R 2 varied between 0.141 and 0.373. The major part of the explained variance in CCA-IMT was because of age and race. Indicators of blood pressure, lipid profile, and adiposity that most frequently composed the best models were pulse pressure, low-density lipoprotein/high-density lipoprotein ratio, and neck circumference. The association between neck circumference and CCA-IMT persisted significant even after further adjustment for vessel sizes and body mass index. Indicators of glucose metabolism had smaller contribution. Conclusions—: We found that >60% of CCA-IMT were not explained by demographic and traditional cardiovascular risk factors, which highlights the need to study novel risk factors. Pulse pressure, low-density lipoprotein/high-density lipoprotein ratio, and neck circumference were the most consistent contributors.

1 September 2016 in Vaccine
Verified
Journal Article
Closed access
VSVictor Suarez
Victor Suarez
FMFabiana Michel
Fabiana Michel
CTCristiana M. Toscano
Cristiana M. Toscano
ABAna Luiza Bierrenbach
Ana Luiza Bierrenbach
MGMarco Gonzales
Marco Gonzales
LOLucia H. de Oliveira
Lucia H. de Oliveira

1 March 2007 in Health Affairs
Verified
Journal Article
Closed access
MSMaria de Fátima Marinho de Souza
Maria de Fátima Marinho de Souza
JMJames Macinko
James Macinko
AAAirlane Alencar
Airlane Alencar
DMDeborah Carvalho Malta
Deborah Carvalho Malta
ONOtaliba Libânio de Morais Neto
Otaliba Libânio de Morais Neto
This paper provides evidence suggesting that gun control measures have been effective in reducing the toll of violence on population health in Brazil. In 2004, for the first time in more than a decade, firearm-related mortality declined 8 percent from the previous year. Firearm-related hospitalizations also reversed a historical trend that year by decreasing 4.6 percent from 2003 levels. These changes corresponded with anti-gun legislation passed in late 2003 and disarmament campaigns undertaken throughout the country since mid-2004. The estimated impact of these measures, if they prove causal, could be as much as 5,563 firearm-related deaths averted in 2004 alone.

10 August 2015 in Influenza and Other Respiratory Viruses
Verified
Journal Article
Open access
PDF file
PCPo‐Yung Cheng
Po‐Yung Cheng
RPRakhee Palekar
Rakhee Palekar
EAEduardo Azziz‐Baumgartner
Eduardo Azziz‐Baumgartner
DIDanielle Iuliano
Danielle Iuliano
AAAirlane Alencar
Airlane Alencar
MWMarc‐Alain Widdowson
Marc‐Alain Widdowson
Background: Influenza disease is a vaccine‐preventable cause of morbidity and mortality. The Pan American Health Organization (PAHO) region has invested in influenza vaccines, but few estimates of influenza burden exist to justify these investments. We estimated influenza‐associated deaths for 35 PAHO countries during 2002–2008.Methods: Annually, PAHO countries report registered deaths. We used respiratory and circulatory (R&C) codes from seven countries with distinct influenza seasonality and high‐quality mortality data to estimate influenza‐associated mortality rates by age group (0–64, 65–74, and ≥75 years) with a Serfling regression model or a negative binomial model. We calculated the percent of all R&C deaths attributable to influenza by age group in these countries (etiologic fraction) and applied it to the age‐specific mortality in 13 countries with good mortality data but poorly defined seasonality. Lastly, we grouped the remaining 15 countries into WHO mortality strata and applied the age and mortality stratum‐specific rate of influenza mortality calculated from the 20 countries. We summed each country's estimate to arrive at an average total annual number and rate of influenza deaths in the Americas.Results: For the 35 PAHO countries, we estimated an annual mean influenza‐associated mortality rate of 2·1/100 000 among <65‐year olds, 31·9/100 000 among those 65–74 years, and 161·8/100 000 among those ≥75 years. We estimated that annually between 40 880 and 160 270 persons (mean, 85 100) die of influenza illness in the PAHO region.Conclusion: Influenza remains an important cause of mortality in the Americas.

1 March 2016 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
RMRoberta Ferreira de Mello
Roberta Ferreira de Mello
ISItamar de Souza Santos
Itamar de Souza Santos
AAAirlane Alencar
Airlane Alencar
IBIsabela Martins Benseñor
Isabela Martins Benseñor
PLPaulo Andrade Lotufo
Paulo Andrade Lotufo
AGAlessandra Carvalho Goulart
Alessandra Carvalho Goulart